FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC: Form 990, tax year 2012
View the entire original 990 at ProPublica ↗
- Organization
- FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC (EIN 52-1986675)
- Tax period
- 2012-01-01 to 2012-12-31
- Filed
- 2013-11-13
- IRS object ID
- 201313179349300741
- Schema version
- 2012v2.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2013-11-13T08:34:34-06:00 | Timestamp |
| Tax Period End Date | 2012-12-31 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 560747981 | EIN |
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DIXON HUGHES GOODMAN LLP | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 111 ROCKVILLE PIKE 6TH FLOOR | AddressLine1 |
| City | ROCKVILLE | City |
| State | MD | State |
| ZIP Code | 20850 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2012-01-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 521986675 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | FOUNDATION FOR THE NATIONAL INSTITUTES | BusinessNameLine1 |
| Business Name Line2 | OF HEALTH INC | BusinessNameLine2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | FOUN | NameControl |
| Phone | 3014025311 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE NO 3411 | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | MARIA FREIRE PHD | Name |
| Title | PRESIDENT | Title |
| Phone | 3014025311 | Phone |
| Date Signed | 2013-10-25 | DateSigned |
| Authorize Third Party | 1 | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | ROBIN SKINNER | Name |
| PTIN | P00742964 | PTIN |
| Phone | 2404033700 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2012 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | MARIA FREIRE PHD | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE NO 3411 | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 87446600 | GrossReceipts |
| Group Return For Affiliates | 0 | GroupReturnForAffiliates |
| Organization501c3 | X | Organization501c3 |
| Web Site | HTTP://WWW.FNIH.ORG | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 2001 | YearFormation |
| State Legal Domicile | MD | StateLegalDomicile |
| Activity Or Mission Description | THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY THE UNITED STATES CONGRESS TO SUPPORT THE NIH IN ITS MISSION TO IMPROVE HEALTH, BY FORMING AND FACILITATING PUBLIC-PRIVATE PARTNERSHIPS FOR BIOMEDICAL RESEARCH AND TRAINING. THE FOUNDATION BUILDS PARTNERSHIP FOR DISCOVERY AND INNOVATION TO IMPROVE HEALTH.IN 2012, OUR PORTFOLIO OF WORK EMBRACED A BROAD CONSTELLATION OF PARTNERS FROM MANY INSTITUTES AND CENTERS WITHIN THE NIH, FROM THE NONPROFIT SECTOR AS WELL AS THE PRIVATE SECTOR, INCLUDING PHARMACEUTICAL, TECHNOLOGY, RETAIL, AND FOOD AND BEVERAGE INDUSTRIES AND FROM ORGANIZATIONS AS DIVERSE AS THE NATIONAL FOOTBALL LEAGUE AND GOOGLE. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 28 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 28 | NbrIndependentVotingMembers |
| Total Nbr Employees | 54 | TotalNbrEmployees |
| Total Nbr Volunteers | 0 | TotalNbrVolunteers |
| Total Gross UBI | 0 | TotalGrossUBI |
| Net Unrelated Business Txbl Income | 0 | NetUnrelatedBusinessTxblIncome |
| Contributions Grants Prior Year | 59765254 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 58869026 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 1549687 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 361074 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 135308 | InvestmentIncomePriorYear |
| Investment Income Current Year | 172757 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 0 | OtherRevenuePriorYear |
| Other Revenue Current Year | 343501 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 61450249 | TotalRevenuePriorYear |
| Total Revenue Current Year | 59746358 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 25483921 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 33629180 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members Prior Year | 0 | BenefitsPaidToMembersPriorYear |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 5571047 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 5483858 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp Prior Year | 0 | TotalProfFundrsngExpPriorYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 141373 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 19448911 | OtherExpensePriorYear |
| Other Expenses Current Year | 11635220 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 50503879 | TotalExpensesPriorYear |
| Total Expenses Current Year | 50748258 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | 10946370 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | 8998100 | RevenuesLessExpensesCY |
| Total Assets BOY | 98055767 | TotalAssetsBOY |
| Total Assets EOY | 104456171 | TotalAssetsEOY |
| Total Liabilities BOY | 13622823 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 12225630 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 84432944 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 92230541 | NetAssetsOrFundBalancesEOY |
| Info In Schedule O Part III | X | InfoInScheduleOPartIII |
| Mission Description | SEE SCHEDULE O, STATEMENT OF ORGANIZATION'S PRIMARY EXEMPT PURPOSE STATEMENT | MissionDescription |
| Significant New Program Services | 0 | SignificantNewProgramServices |
| Significant Change | 0 | SignificantChange |
| Expense | 45017288 | Expense |
| Grants | 32158554 | Grants |
| Revenue | 361074 | Revenue |
| Description | SEE SCHEDULE O, PROGRAM ONE, RESEARCH PARTNERSHIPS | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 1325295 | Expense |
| Grants | 1123567 | Grants |
| Description | SEE SCHEDULE O, PROGRAM TWO, FELLOWSHIPS AND TRAINING PROGRAMS | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 35100 | Expense |
| Grants | 8298 | Grants |
| Description | SEE SCHEDULE O, PROGRAM THREE, CAPITAL PROJECTS | Description |
Activity Other ActivityOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 1246180 | Expense |
| Grants | 338761 | Grants |
| Description | SEE SCHEDULE O, MEMORIALS, AWARDS AND EVENTS | Description |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Other Program Service Exp | 1246180 | TotalOfOtherProgramServiceExp |
| Total Of Other Program Service Grnt | 338761 | TotalOfOtherProgramServiceGrnt |
| Total Program Service Expense | 47623863 | TotalProgramServiceExpense |
| Described In501 C3 | 1 | DescribedIn501C3 |
| Schedule B Required | 1 | ScheduleBRequired |
| Political Activities | 0 | PoliticalActivities |
| Lobbying Activities | 0 | LobbyingActivities |
| Subject To Proxy Tax | 0 | SubjectToProxyTax |
| Donor Advised Funds | 1 | DonorAdvisedFunds |
| Conservation Easements | 0 | ConservationEasements |
| Collections Of Art | 0 | CollectionsOfArt |
| Credit Counseling | 1 | CreditCounseling |
| Term Or Permanent Endowments | 1 | TermOrPermanentEndowments |
| Report Land Bldg Equip | 1 | ReportLandBldgEquip |
| Report Invest Oth Securities | 1 | ReportInvestOthSecurities |
| Report Prog Rel Invest | 0 | ReportProgRelInvest |
| Report Other Assets | 0 | ReportOtherAssets |
| Report Other Liabilities | 1 | ReportOtherLiabilities |
| Report Fin48 Footnote | 1 | ReportFin48Footnote |
| Independent Audit Financial Stmt | 1 | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | 0 | ConsolidatedAuditFinancialStmt |
| School | 0 | School |
| Foreign Office | 0 | ForeignOffice |
| Foreign Activities | 1 | ForeignActivities |
| More Than5000 K To Organizations | 1 | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividuals |
| Professional Fundraising | 0 | ProfessionalFundraising |
| Fundraising Activities | 0 | FundraisingActivities |
| Gaming | 0 | Gaming |
| Hospital | 0 | Hospital |
| Grants To Organizations | 1 | GrantsToOrganizations |
| Grants To Individuals | 1 | GrantsToIndividuals |
| Schedule J Required | 1 | ScheduleJRequired |
| Tax Exempt Bonds | 0 | TaxExemptBonds |
| Excess Benefit Transaction | 0 | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | 0 | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | 0 | LoanToOfficerOrDQP |
| Grant To Related Person | 0 | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | 0 | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | 0 | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | 0 | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | 0 | DeductibleNonCashContributions |
| Deductible Contributions Of Art | 0 | DeductibleContributionsOfArt |
| Terminated | 0 | Terminated |
| Partial Liquidation | 0 | PartialLiquidation |
| Disregarded Entity | 0 | DisregardedEntity |
| Related Entity | 0 | RelatedEntity |
| Related Org Controlled Entity | 0 | RelatedOrgControlledEntity |
| Transfers To Exempt Non Chrtbl Org | 0 | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | 0 | ActivitiesConductedPartnership |
| Schedule O Required | 1 | ScheduleORequired |
| Number Forms Transmitted With1096 | 31 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Compliance With Backup Witholding | 1 | ComplianceWithBackupWitholding |
| Number Of Employees | 54 | NumberOfEmployees |
| Employment Tax Returns Filed | 1 | EmploymentTaxReturnsFiled |
| Unrelated Business Income | 0 | UnrelatedBusinessIncome |
| Foreign Financial Account | 0 | ForeignFinancialAccount |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTrans |
| Taxable Party Notification | 0 | TaxablePartyNotification |
| Non Deductible Contributions | 0 | NonDeductibleContributions |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributions |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | 0 | FundsToPayPremiums |
| Premiums Paid | 0 | PremiumsPaid |
| Excess Business Holdings | 0 | ExcessBusinessHoldings |
| Taxable Distributions | 0 | TaxableDistributions |
| Distribution To Donor | 0 | DistributionToDonor |
| Indoor Tanning Services | 0 | IndoorTanningServices |
| Info In Schedule O Part VI | X | InfoInScheduleOPartVI |
| Nbr Voting Governing Body Members | 28 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 28 | NumberIndependentVotingMembers |
| Family Or Business Relationship | 0 | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | 0 | DelegationOfManagementDuties |
| Changes To Organizing Docs | 0 | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuse |
| Members Or Stockholders | 0 | MembersOrStockholders |
| Election Of Board Members | 0 | ElectionOfBoardMembers |
| Decisions Subject To Approval | 0 | DecisionsSubjectToApproval |
| Minutes Of Governing Body | 1 | MinutesOfGoverningBody |
| Minutes Of Committees | 1 | MinutesOfCommittees |
| Officer Mailing Address | 0 | OfficerMailingAddress |
| Local Chapters | 0 | LocalChapters |
| Form990 Provided To Governing Body | 1 | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | 1 | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | 1 | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | 1 | RegularMonitoringEnforcement |
| Whistleblower Policy | 1 | WhistleblowerPolicy |
| Document Retention Policy | 1 | DocumentRetentionPolicy |
| Compensation Process CEO | 1 | CompensationProcessCEO |
| Compensation Process Other | 1 | CompensationProcessOther |
| Investment In Joint Venture | 0 | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AZ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CO | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | GA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | HI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ME | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NJ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NM | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ND | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | RI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | SC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | UT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WV | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WI | StatesWhereCopyOfReturnIsFiled |
| Own Website | X | OwnWebsite |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JULIE TUNE | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Telephone Number | 3014025311 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (43 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | Key EmployeeKeyEmployee | Highest Compensated EmployeeHighestCompensatedEmployee | FormerFormer |
|---|---|---|---|---|---|---|---|---|
| CHARLES A SANDERS MD | ||||||||
| CHAIRMAN | 2.00 | X | 0 | 0 | 0 | |||
| PAUL M MONTRONE PHD | ||||||||
| TREASURER | 1.50 | X | 0 | 0 | 0 | |||
| JOHN EDWARD PORTER | ||||||||
| VICE CHAIRMAN | 1.50 | X | 0 | 0 | 0 | |||
| MRS WILLIAM MCCORMICK BLAIR JR | ||||||||
| SECRETARY | 1.00 | X | 0 | 0 | 0 | |||
| MRS WILLIAM N CAFRITZ | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| ANN LURIE | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| JOSEPH M FECZKO MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| MILES GILBURNE | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| SHERRY LANSING | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| MARTIN MURPHY JR MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| STEVEN M PAUL MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| JILLIAN SACKLER DBE | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| LILY SAFRA | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| ELLEN V SIGAL PHD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| SOLOMON H SNYDER MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| SAMUEL O THIER MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| PATRICK C WALSH MD | ||||||||
| HONORARY DIRECTOR | 0.50 | X | 0 | 0 | 0 | |||
| ANNE WOJCICKI | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| PAUL BERG PHD | ||||||||
| DIRECTOR EMERITUS | 0.50 | X | 0 | 0 | 0 | |||
| LUTHER W BRADY MD | ||||||||
| HONORARY DIRECTOR | 0.50 | X | 0 | 0 | 0 | |||
| FREDA C LEWIS-HALL MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| MARIA FREIRE PHD | ||||||||
| PRESIDENT | 40.00 | X | 62048 | 0 | 11248 | |||
| NINA SOLARZ | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| JAMES H DONOVAN | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| PAUL L HERRLING PHD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| RONALD L KRALL MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| EDISON T LIU MD PHD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| JOEL S MARCUS | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| STEVEN C MAYER | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| GARRY A NEIL MD | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| KATHY BLOOMGARDEN | ||||||||
| BOARD MEMBER | 0.50 | X | 0 | 0 | 0 | |||
| DAVID WHOLLEY | ||||||||
| DIR BIOMARKERS CONSORTIUM | 40.00 | 266107 | 0 | 35752 | X | |||
| STEPHANIE JAMES | ||||||||
| DIR OF SCIENCE AND GCGH | 40.00 | 269172 | 0 | 25000 | X | |||
| ANDREA BARUCHIN | ||||||||
| DIR NIH RELATIONS | 40.00 | 187953 | 0 | 23751 | X | |||
| JULIE TUNE | ||||||||
| CHIEF FINANCIAL OFFICER | 40.00 | 173184 | 0 | 28070 | X | |||
| ANN ASHBY | ||||||||
| DEPUTY EXECUTIVE DIRECTOR | 40.00 | 198758 | 0 | 30628 | X | |||
| JULIA WOLF-RODDA | ||||||||
| DIR PSHIP DEVELOPMENT | 40.00 | 176611 | 0 | 28413 | X | |||
| MICHAEL GOTTLIEB | ||||||||
| ASSOC DIR OF SCIENCE | 40.00 | 220833 | 0 | 22083 | X | |||
| JUDITH SIUCIAK | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | 149220 | 0 | 25674 | X | |||
| GAIL LEVINE | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | 140804 | 0 | 24832 | X | |||
| SONIA PEARSON-WHITE | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | 120307 | 0 | 16987 | X | |||
| KAREN TOUNTAS | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | 143830 | 0 | 25135 | X | |||
| SCOTT CAMPBELL | ||||||||
| FORMER EXECUTIVE DIRECTOR AND CEO | 40.00 | 241015 | 0 | 29057 | X | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 2349842 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 0 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 326630 | TotalOtherCompensation |
| Number Individuals GT100 K | 14 | NumberIndividualsGT100K |
| Formers Listed | 1 | FormersListed |
| Total Comp GT150 K | 1 | TotalCompGT150K |
| Compensation From Other Sources | 0 | CompensationFromOtherSources |
Contractor Compensation ContractorCompensation (5 entries)
| Address Line1AddressOfContractor/AddressUS/AddressLine1 | CityAddressOfContractor/AddressUS/City | StateAddressOfContractor/AddressUS/State | ZIP CodeAddressOfContractor/AddressUS/ZIPCode | Description Of ServicesDescriptionOfServices | CompensationCompensation |
|---|---|---|---|---|---|
| CCS ASSOCIATES | |||||
| PO BOX 9125 | MCLEAN | VA | 22102 | CONSULTING | 1160271 |
| EPHIR INC | |||||
| PO BOX 253 | SWAMPSCOTT | MA | 01907 | RESARCH LAB RELEASE MANAGEMENT | 1157812 |
| DIGITAL AURORA | |||||
| PO BOX 648 174 SARGENT LANE | MANCHESTER | VT | 05254 | CONSULTING | 635914 |
| AMAZON WEB SERVICES LLC | |||||
| PO BOX 84023 | SEATTLE | WA | 98124 | WEB SERVICES | 340225 |
| TRUVEN HEALTH ANALYTICS INC | |||||
| PO BOX 71716 | CHICAGO | IL | 60694 | CONSULTING | 262500 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of Contractors GT100 K | 18 | NumberOfContractorsGT100K |
| Government Grants | 514000 | GovernmentGrants |
| All Other Contributions | 58355026 | AllOtherContributions |
| Total Contributions | 58869026 | TotalContributions |
Program Service Revenue ProgramServiceRevenue (2 entries)
| DescriptionDescription | Business CodeBusinessCode | Total Revenue ColumnTotalRevenueColumn | Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome |
|---|---|---|---|
| ADMINISTRATIVE FEES | 561000 | 260551 | 260551 |
| REGISTRATION AND EXHIBIT FEES | 541700 | 100523 | 100523 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | 361074 | TotalProgramServiceRevenue |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 140900 | TotalRevenueColumn |
| Exclusion | $140,900 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 27732099 | Securities |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 27700242 | Securities |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 31857 | Securities |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 31857 | TotalRevenueColumn |
| Exclusion | $31,857 | ExclusionAmount |
Other Revenue Misc OtherRevenueMisc
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description | MISCELLANEOUS REVENUE | Description |
| Business Code | 541700 | BusinessCode |
| Total Revenue Column | 343501 | TotalRevenueColumn |
| Exclusion | $343,501 | ExclusionAmount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Revenue | 343501 | TotalOtherRevenue |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 59746358 | TotalRevenueColumn |
| Related Or Exempt Function Income | 361074 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 0 | UnrelatedBusinessRevenue |
| Exclusion | $516,258 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 21724141 | Total |
| Program Services | 21724141 | ProgramServices |
Grants To Domestic Individuals GrantsToDomesticIndividuals
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 241750 | Total |
| Program Services | 241750 | ProgramServices |
Foreign Grants ForeignGrants
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 11663289 | Total |
| Program Services | 11663289 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2662974 | Total |
| Program Services | 1717979 | ProgramServices |
| Management And General | 927811 | ManagementAndGeneral |
| Fundraising | 17184 | Fundraising |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1855909 | Total |
| Program Services | 976965 | ProgramServices |
| Management And General | 796186 | ManagementAndGeneral |
| Fundraising | 82758 | Fundraising |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 664855 | Total |
| Program Services | 358674 | ProgramServices |
| Management And General | 284664 | ManagementAndGeneral |
| Fundraising | 21517 | Fundraising |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 300120 | Total |
| Program Services | 149422 | ProgramServices |
| Management And General | 150698 | ManagementAndGeneral |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 336622 | Total |
| Program Services | 312857 | ProgramServices |
| Management And General | 23765 | ManagementAndGeneral |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 56859 | Total |
| Management And General | 56859 | ManagementAndGeneral |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 19056 | Total |
| Program Services | 9056 | ProgramServices |
| Management And General | 10000 | ManagementAndGeneral |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 26308 | Total |
| Program Services | 10979 | ProgramServices |
| Management And General | 15096 | ManagementAndGeneral |
| Fundraising | 233 | Fundraising |
Information Technology InformationTechnology
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 712920 | Total |
| Program Services | 637871 | ProgramServices |
| Management And General | 75049 | ManagementAndGeneral |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 395460 | Total |
| Program Services | 184899 | ProgramServices |
| Management And General | 210561 | ManagementAndGeneral |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1595045 | Total |
| Program Services | 1496357 | ProgramServices |
| Management And General | 97096 | ManagementAndGeneral |
| Fundraising | 1592 | Fundraising |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 54414 | Total |
| Management And General | 54414 | ManagementAndGeneral |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 167788 | Total |
| Program Services | 122030 | ProgramServices |
| Management And General | 45758 | ManagementAndGeneral |
Other Expenses OtherExpenses (4 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral | FundraisingFundraising |
|---|---|---|---|---|
| PROGRAM CONTRACTS | 4324306 | 4324306 | ||
| CONSULTANTS | 4133561 | 4076393 | 57168 | |
| SERVICE CHARGES | 109597 | 31788 | 77809 | |
| PRINTING AND PHOTOCOPYI | 61169 | 30524 | 18770 | 11875 |
All Other Expenses AllOtherExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | -357885 | Total |
| Program Services | -445417 | ProgramServices |
| Management And General | 81318 | ManagementAndGeneral |
| Fundraising | 6214 | Fundraising |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 50748258 | Total |
| Program Services | 47623863 | ProgramServices |
| Management And General | 2983022 | ManagementAndGeneral |
| Fundraising | 141373 | Fundraising |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 55108789 | BOY |
| EOY | 31522531 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 18080849 | BOY |
| EOY | 11784082 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 102130 | BOY |
| EOY | 412305 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 611770 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 538071 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 105697 | BOY |
| EOY | 73699 | EOY |
Investments Other Securities InvestmentsOtherSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 24658302 | BOY |
| EOY | 60663554 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 98055767 | BOY |
| EOY | 104456171 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2561263 | BOY |
| EOY | 1885572 | EOY |
Deferred Revenue DeferredRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 7862751 | BOY |
| EOY | 6386906 | EOY |
Escrow Account Liability EscrowAccountLiability
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3198809 | BOY |
| EOY | 3776556 | EOY |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 0 | BOY |
| EOY | 176596 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 13622823 | BOY |
| EOY | 12225630 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 10078788 | BOY |
| EOY | 10797929 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 71045848 | BOY |
| EOY | 78113876 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3308308 | BOY |
| EOY | 3318736 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 84432944 | BOY |
| EOY | 92230541 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 98055767 | BOY |
| EOY | 104456171 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | X | InfoInScheduleOPartXI |
| Reconcilation Revenue Expenses | 8998100 | ReconcilationRevenueExpenses |
| Reconciliation Unrealized Invest | 74497 | ReconciliationUnrealizedInvest |
| Reconcilation Other Changes | -1275000 | ReconcilationOtherChanges |
| Info In Schedule O Part XII | X | InfoInScheduleOPartXII |
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | 0 | AccountantCompileOrReview |
| FS Audited | 1 | FSAudited |
FS Audited Basis FSAuditedBasis
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Statement Separate | X | FinancialStatementSeparate |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | 1 | AuditCommittee |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequired |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org170b1 Avi | X | PubliclySupportedOrg170b1Avi |
Gifts Grants Contrib Received170 GiftsGrantsContribReceived170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 81264504 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 71174551 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 61850631 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 59279254 | CurrentTaxYearMinus1Year |
| Current Tax Year | 58355026 | CurrentTaxYear |
| Total | 331923966 | Total |
Value Srvc Fclts Furnished By Govt ValueSrvcFcltsFurnishedByGovt
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 584653 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 503112 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 500000 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 486000 | CurrentTaxYearMinus1Year |
| Current Tax Year | 514000 | CurrentTaxYear |
| Total | 2587765 | Total |
Total170 Total170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 81849157 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 71677663 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 62350631 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 59765254 | CurrentTaxYearMinus1Year |
| Current Tax Year | 58869026 | CurrentTaxYear |
| Total | 334511731 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Amounts Subst Contributors Total | 127072948 | AmountsSubstContributorsTotal |
| Public Support Total170 | 207438783 | PublicSupportTotal170 |
Gross Investment Income170 GrossInvestmentIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 3698901 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 806143 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 173991 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 134140 | CurrentTaxYearMinus1Year |
| Current Tax Year | 140900 | CurrentTaxYear |
| Total | 4954075 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | 339465806 | TotalSupport |
| Gross Receipts From Admissions Etc | 3069458 | GrossReceiptsFromAdmissionsEtc |
| Public Support Pertcentage170 | 0.61110 | PublicSupportPertcentage170 |
| Public Support Pertcent Prior Year | 0.47320 | PublicSupportPertcentPriorYear |
| Thirty Three Percnt Tests CY170 | X | ThirtyThreePercntTestsCY170 |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number DA Fs Held | 2 | NumberDAFsHeld |
| Donor Advised Contributions | 4725 | DonorAdvisedContributions |
| Grants Paid From Donor Funds | 458738 | GrantsPaidFromDonorFunds |
| Aggregate DAF Value | 6664514 | AggregateDAFValue |
| Disclosed Orgs Legal Control | 1 | DisclosedOrgsLegalControl |
| Disclosed For Charitable Purposes | 1 | DisclosedForCharitablePurposes |
| Agent Trustee Etc | 0 | AgentTrusteeEtc |
| Included On FS | 1 | IncludedOnFS |
| Explanation In Part XIII | X | ExplanationInPartXIII |
Current Year CurrentYear
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 3630634 | BeginningOfYearBalance |
| Contributions | 15153 | Contributions |
| Investment Earnings Or Losses | 25996 | InvestmentEarningsOrLosses |
| Administrative Expenses | 61840 | AdministrativeExpenses |
| End Of Year Balance | 3609943 | EndOfYearBalance |
Current Year Minus1 Year CurrentYearMinus1Year
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 3690564 | BeginningOfYearBalance |
| Contributions | 3214 | Contributions |
| Investment Earnings Or Losses | -91 | InvestmentEarningsOrLosses |
| Administrative Expenses | 63053 | AdministrativeExpenses |
| End Of Year Balance | 3630634 | EndOfYearBalance |
Current Year Minus2 Years CurrentYearMinus2Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 3736712 | BeginningOfYearBalance |
| Contributions | 9744 | Contributions |
| Investment Earnings Or Losses | 23343 | InvestmentEarningsOrLosses |
| Administrative Expenses | 79235 | AdministrativeExpenses |
| End Of Year Balance | 3690564 | EndOfYearBalance |
Current Year Minus3 Years CurrentYearMinus3Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 3791493 | BeginningOfYearBalance |
| Contributions | 20898 | Contributions |
| Investment Earnings Or Losses | 48619 | InvestmentEarningsOrLosses |
| Administrative Expenses | 124298 | AdministrativeExpenses |
| End Of Year Balance | 3736712 | EndOfYearBalance |
Current Year Minus4 Years CurrentYearMinus4Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 3777493 | BeginningOfYearBalance |
| Contributions | 10445 | Contributions |
| Investment Earnings Or Losses | 104761 | InvestmentEarningsOrLosses |
| Administrative Expenses | 101206 | AdministrativeExpenses |
| End Of Year Balance | 3791493 | EndOfYearBalance |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Permanent Endowment EOY Balance | 0.92000 | PermanentEndowmentEOYBalance |
| Term Endowment EOY Balance | 0.08000 | TermEndowmentEOYBalance |
| Endowments Held By Unrelated Orgs | 0 | EndowmentsHeldByUnrelatedOrgs |
| Endowments Held By Related Orgs | 0 | EndowmentsHeldByRelatedOrgs |
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 464079 | OtherCostOrOtherBasis |
| Depreciation | 392803 | Depreciation |
| Book Value | 71276 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 147691 | OtherCostOrOtherBasis |
| Depreciation | 145268 | Depreciation |
| Book Value | 2423 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 73699 | TotalOfBookValueLandBuildings |
Other Securities OtherSecurities (7 entries)
| DescriptionDescription | Book ValueBookValue | Method Of ValuationMethodOfValuation |
|---|---|---|
| BOND MUTUAL FUNDS | 630805 | F |
| EQUITY MUTUAL FUNDS | 304585 | F |
| CORPORATE BONDS | 171076 | F |
| GOVERNMENT BONDS | 59012182 | F |
| STOCKS | 504783 | F |
| REIT | 18876 | F |
| EXCHANGE TRADED FUNDS | 21247 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Securities | 60663554 | TotalOfBookValueSecurities |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description | CHARITABLE GIFT ANNUITY | Description |
| Amount | $176,596 | Amount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Amounts | 176596 | TotalOfAmounts |
| Footnote In Part XIII | X | FootnoteInPartXIII |
| Tot Revenue Etc Audited Fincl Stmt | 58837782 | TotRevenueEtcAuditedFinclStmt |
| Net Unrealized Gains Investments | 74497 | NetUnrealizedGainsInvestments |
| Donated Srvc And Use Of Facilities | 41000 | DonatedSrvcAndUseOfFacilities |
| Other Revenues | -1024073 | OtherRevenues |
| Revenue Not Rptd F990 | -908576 | RevenueNotRptdF990 |
| Revenue Subtotal | 59746358 | RevenueSubtotal |
| Revenue Not Rptd On Fin Stmt | 0 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 59746358 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 51040185 | TotExpensesEtcAuditedFinclStmt |
| Donated Services Use Of Facilities | 41000 | DonatedServicesUseOfFacilities |
| Other Expenses Included | 250927 | OtherExpensesIncluded |
| Expenses Not Rptd F990 | 291927 | ExpensesNotRptdF990 |
| Expenses Subtotal | 50748258 | ExpensesSubtotal |
| Expenses Not Rptd On Fin Stmt | 0 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 50748258 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIII Form990ScheduleDPartXIII (5 entries)
| Return ReferenceReturnReference | ExplanationExplanation | IdentifierIdentifier |
|---|---|---|
| PART IV, LINE 2B: | AS OF 12/31/2012, THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC HELD $3,776,556 IN AGENCY FUNDS FOR FUTURE DISTRIBUTIONS TO THE NATIONAL INSTITUTES OF HEALTH (NIH). THESE FUNDS ARE DESIGNATED BY THE FUNDER(S) FOR SPECIFIC PROJECTS AT THE NIH, AND WILL BE DISBURSED AS NEEDED. | |
| PART V, LINE 4: | THE FOUNDATION'S ENDOWMENTS CONSIST OF INDIVIDUAL DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR A VARIETY OF PURPOSES. (E.G. VARIETY OF RESEARCH AND EDUCATIONAL INITIATIVES AT THE FOUNDATION FOR THE NIH). NET ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OF DONOR-IMPOSED RESTRICTIONS. | DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: |
| PART X, LINE 2: | THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAS DETERMINED THAT IT DOES NOT HAVE ANY MATERIAL UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS AS OF DECEMBER 31, 2012 AND 2011. FISCAL YEARS ENDING ON OR AFTER DECEMBER 31, 2009 REMAIN SUBJECT TO EXAMINATION BY FEDERAL AND STATE TAX AUTHORIES. | DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: |
| IN KIND CONTRIBUTIONS REDUCTION IN FUTURE PLEDGES | PART XI, LINE 2D - OTHER ADJUSTMENTS: | |
| IN KIND CONTRIBUTIONS | PART XII, LINE 2D - OTHER ADJUSTMENTS: |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 1 | GrantRecordsMaintained |
Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)
| RegionRegion | Number Of OfficesNumberOfOffices | Number Of EmployeesNumberOfEmployees | Type Of Activities ConductedTypeOfActivitiesConducted | Total ExpendituresTotalExpenditures |
|---|---|---|---|---|
| EAST ASIA & THE PACIFIC | 0 | 0 | GRANTMAKING | 4233212 |
| EUROPE | 0 | 0 | GRANTMAKING | 5879397 |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTMAKING | 224049 |
| SOUTH ASIA | 0 | 0 | GRANTMAKING | 1326631 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Number Of Offices | 0 | SubtotalNumberOfOffices |
| Subtotal Number Of Employees | 0 | SubtotalNumberOfEmployees |
| Cont Number Of Offices | 0 | ContNumberOfOffices |
| Cont Number Of Employees | 0 | ContNumberOfEmployees |
| Total Number Of Offices | 0 | TotalNumberOfOffices |
| Total Number Of Employees | 0 | TotalNumberOfEmployees |
| Subtotal Amount Spent | 11663289 | SubtotalAmountSpent |
| Cont Amount Spent | 0 | ContAmountSpent |
| Total Amount Spent | 11663289 | TotalAmountSpent |
Grants To Orgs Outside US GrantsToOrgsOutsideUS (11 entries)
| RegionRegion | Purpose Of GrantPurposeOfGrant | Amount Of Cash GrantAmountOfCashGrant | Manner Of Cash DisbursementMannerOfCashDisbursement |
|---|---|---|---|
| EUROPE | DEVELOP A GENETIC STRATEGY TO DEPLETE OR INCAPACITATE INSECTS | 4813262 | WIRE TRANSFER |
| EUROPE | NON-HUMAN PRIMATE CORE | 50775 | WIRE TRANSFER |
| SOUTH ASIA | MALNUTRITION AND ENTERIC DISEASES NETWORK | 783616 | WIRE TRANSFER |
| SOUTH ASIA | MALNUTRITION AND ENTERIC DISEASES NETWORK | 543015 | WIRE TRANSFER |
| EUROPE | IMMUNOGENICITY STUDY(CECI) | 13333 | WIRE TRANSFER |
| EUROPE | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | 359136 | WIRE TRANSFER |
| SUB-SAHARAN AFRICA | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | 224049 | WIRE TRANSFER |
| EAST ASIA AND THE PACIFIC | MODIFYING MOSQUITO POPULATION AGE STRUCTURE TO ELIMINATE DENGUE TRANSMISSION | 4183075 | WIRE TRANSFER |
| EUROPE | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | 422658 | WIRE TRANSFER |
| EUROPE | DETECTION OF LONG TERM ADVERSE DRUG REACTIONS IN ELECTRONIC HEALTH CARE DATA | 220233 | WIRE TRANSFER |
| EAST ASIA AND THE PACIFIC | BIOMARKERS OSTEOARTHRITIS | 50137 | WIRE TRANSFER |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of501c3 Orgs | 11 | TotalNumberOf501c3Orgs |
| Total Number Of Other Orgs | 1 | TotalNumberOfOtherOrgs |
| Transfer To Foreign Corp | 0 | TransferToForeignCorp |
| Interest In Foreign Trust | 0 | InterestInForeignTrust |
| Own Foreign Corp | 0 | OwnForeignCorp |
| Passive Foreign Invest Co | 0 | PassiveForeignInvestCo |
| Foreign Partnership | 0 | ForeignPartnership |
| Boycott Countries | 0 | BoycottCountries |
Form990 Schedule F Part V Form990ScheduleFPartV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: | Identifier |
| Explanation | SCHEDULE F, PART I, LINE 2: PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS SOME DEVELOPING COUNTRY INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. | Explanation |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | 1 | RecordsMaintained |
Recipient Table RecipientTable (38 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EIN Of RecipientEINOfRecipient | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant | Address Line2AddressUS/AddressLine2 |
|---|---|---|---|---|---|---|---|---|
| BETH ISRAEL DEACONESS MEDICAL CENTER | ||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042103881 | 501(C)(3) | 312096 | NON HUMAN PRIMATE NEW ASSAY | |
| CALIFORNIA PACIFIC MEDICAL CENTER | ||||||||
| 475 BRANNAN STREET SUITE 220 | SAN FRANCISCO | CA | 94107 | 950562680 | 501(C)(3) | 10000 | SARCOPENIA | |
| DUKE UNIVERSITY | ||||||||
| 2200 WEST MAIN STREET SUITE 820 | DURHAM | NC | 27705 | 560532129 | 501(C)(3) | 1143084 | PROFICIENCY TESTING CENTRAL/CECI | ERWIN SQUARE PLAZA |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 872491 | VIMC/INNATE AND MUCOSAL IMMUNITY DISCOVERY TEAM | |
| JOHNS HOPKINS UNIVERSITY | ||||||||
| 615 N WOLFE ST W1100 | BALTIMORE | MD | 21205 | 150595110 | 501(C)(3) | 616862 | MAL-ED | |
| TRUSTEES OF COLUMBIA UNIVERSITY OF THE CITY OF NEW YORK | ||||||||
| 630 WEST 168TH STREET | NEW YORK | NY | 10032 | 135598093 | 501(C)(3) | 135311 | MOLECULAR APPROACHES TO ALTER OLFACTORY-DRIVEN BEHAVIORS OF INSECT DISEASE VECTORS | |
| UNIVERSITY OF MARYLAND BALTIMORE | ||||||||
| PO BOX 41428 | BALTIMORE | MD | 21203 | 311678679 | 170(C)(1) | 10000 | SARCOPENIA | |
| UNIVERSITY OF VIRGINIA | ||||||||
| PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | 546001796 | 170(C)(1) | 4570722 | MAL-ED | |
| VACCINE AND GENE THERAPY INSTITUTE FLORIDA | ||||||||
| 11350 SW VILLAGE PARKWAY THIRD | PORT ST LUCIE | FL | 34987 | 364631835 | 170(C)(1) | 1015550 | VIMC/INNATE AND MUCOSAL IMMUNITY DISCOVERY TEAM | FLOOR |
| COLORADO STATE UNIVERSITY | ||||||||
| 601 HOWES STREET | FORT COLLINS | CO | 80523 | 846000545 | 170(C)(1) | 466553 | MOLECULAR MOSQUITOCIDES: DEVELOPMENT OF AN INNOVATIVE AND ROBUST, PLATFORM-BASED APPROACH FOR SUSTAINABLE INSECTICIDAL CONTROL OF ANOPHELINE MOSQUITOES | |
| NIH-FIC | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 763361 | RESEARCH | |
| THE OHIO STATE UNIVERSITY | ||||||||
| 1960 KENNY RD | COLOMBUS | OH | 43210 | 316025986 | 170(C)(1) | 466655 | HIGH THROUGHPUT DISCOVERY OF CHEMICALS THAT INDUCE 'KIDNEY' FAILURE IN THE MALARIAL VECTOR ANOPHELES GAMBIAE | |
| UNIVERSITY OF FLORIDA BOARD OF TRUSTEES | ||||||||
| PO BOX 115500 | GAINESVILLE | FL | 23611 | 596002052 | 170(C)(1) | 460005 | VOLTAGE-SENSITIVE POTASSIUM CHANNEL AS NEW TARGET FOR MOSQUITOCIDES | |
| VESTARON CORPORATION | ||||||||
| 4717 CAMPUS DRIVE SUITE 1200 | KALAMAZOO | MI | 49008 | 203831543 | 444678 | DEVELOPMENT OF SYNTHETIC CHEMICAL MIMICS OF SELECTIVELY INSECTICIDAL NATURAL PEPTIDES | ||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 1620 TREMONT STREET 3RD FLOOR RM BC | BOSTON | MA | 02120 | 042312909 | 501(C)(3) | 189418 | EVALUATION OF THE EFFECTS OF FCRN MUTATIONS ON ANTIBODY HALF-LIFE. | 3002 |
| DALLAS COUNTY HEALTH DEPARTMENT | ||||||||
| 1011 W MAIN PO BOX 199 | BUFFALO | MO | 65622 | 431268846 | 170(C)(1) | 10159 | HEART TRUTH -WOMEN, NUMBERS, HEART, LIFESTYLE | |
| DIVAS MPH | ||||||||
| PO BOX 445 | COLLEGE PARK | MD | 20741 | 271075779 | 501(C)(3) | 37550 | HEART TRUTH HEALTH EDUCATION, ACTION, RESOURCES & TRAINING | |
| DONALD DANFORTH PLANT SCIENCE CENTER | ||||||||
| 975 NORTH WARSON ROAD | ST LOUIS | MO | 63132 | 311584621 | 501(C)(3) | 296387 | REGULATORY DEVELOPMENT FOR HEG-MODIFIED MOSQUITOES | |
| HEBREW REHABILITATION CENTER | ||||||||
| 1200 CENTER STREET | BOSTON | MA | 02131 | 042104298 | 501(C)(3) | 10000 | SARCOPENIA | |
| HENRY JACKSON FOUNDATION (USMHRP ) | ||||||||
| 1401 ROCKVILLE PIKE SUITE 600 | ROCKVILLE | MD | 20852 | 521317896 | 501(C)(3) | 624479 | PROFICIENCY TESTING/MAL-ED | |
| NORTHEAST DISTRICT DEPARTMENT OF HEALTH | ||||||||
| 69 SOUTH MAIN STREET UNIT 4 | BROOKLYN | CT | 06234 | 060896288 | 170(C)(1) | 115000 | THE MODEL OF HEART TRUTH HEALTH CAMPAIGN : FOLLOW THE FIFTY | |
| NORTH COUNTRY HEALTH CONSORTIUM INC | ||||||||
| 262 COTTAGE STREET SUITE 230 | LITTLETON | NH | 03561 | 020503184 | 501(C)(3) | 42987 | HEART TRUTH AWARENESS IN THE NORTH COUNTRY | |
| NIH- NCCAM | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 6008 | RESEARCH | |
| NIH- CLINICAL CENTER | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 885057 | RESEARCH | |
| NIHNCI | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 1809828 | RESEARCH | |
| NIHNHLBI | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 34056 | RESEARCH | |
| NIHNIAID | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 4289825 | RESEARCH | |
| NIHNIDDK | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 338898 | RESEARCH | |
| NIHNIMH | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 558754 | RESEARCH | |
| NIHNINDS | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) | 49900 | RESEARCH | |
| REFUGEE WOMEN'S ALLIANCE | ||||||||
| 4008 MARTIN LUTHER KING JR WAY SO | SEATTLE | WA | 98108 | 911296964 | 501(C)(3) | 49992 | REFUGEE WOMEN'S ALLIANCE | |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES | ||||||||
| BOX 951406-1100 KINROSS AVENUE 211 | LOS ANGELES | CA | 90095 | 956006143 | 501(C)(3) | 15705 | HIGH PERFORMANCE STATISTICAL INFERENCE FOR OMOP | |
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||
| NW 5957 PO BOX 1450 | MINNEAPOLIS | MN | 55485 | 416007513 | 170(C)(1) | 155800 | ANALYSIS OF VRC01 LOCALIZATION IN GUT MUCOSA AND CERVICOVAGINAL SECRETIONS WITH WILD TYPE AND MUTANT VRC01 | |
| SAGE BIONETWORKS | ||||||||
| 1100 FAIRVIEW AVENUE NORTH M1-C108 | SEATTLE | WA | 98109 | 264489946 | 170(B)(1)(A)(VI) | 259361 | BREAST CANCER SUMMIT | |
| ST ELIZABETH MEDICAL CENTER INC | ||||||||
| ONE MEDICAL VILLAGE DRIVE FOUNDATIO | EDGEWOOD | KY | 41017 | 610445850 | 501(C)(3) | 58092 | HEART TRUTH-WOMEN TAKE CARE: THE YEAR FOR YOU. | DEPARTMENT |
| TRUSTEES OF BOSTON UNIVERSITY | ||||||||
| 85 E NEWTON ST M-921 | BOSTON | MA | 02118 | 042103547 | 501(C)(3) | 456238 | ILLUMINATING THE CELLULAR TROPISM OF MEASLES VACCINE VIRUSES IN MACAQUES | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||
| 1855 FOLSOM STREET/MCB425- BOX 0897 | SAN FRANCISCO | CA | 94143 | 946036493 | 501(C)(3) | 100000 | OSTEOARTHRITIS | |
| UNIVERSITY OF PITTSBURGH | ||||||||
| 3100 CATHERDRAL OF LEARNING | PITTSBURGH | PA | 15260 | 250965591 | 501(C)(3) | 28750 | SARCOPENIA | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 35 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 3 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part III Form990ScheduleIPartIII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Type Of Grant | AWARDS | TypeOfGrant |
| Number Of Recipients | 9 | NumberOfRecipients |
| Amount Of Cash Grant | 210000 | AmountOfCashGrant |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURE FOR MONITORING GRANTS IN THE U.S.: | Identifier |
| Return Reference | PART I, LINE 2: | ReturnReference |
| Explanation | SCHEDULE I, PART I, LINE 2: PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS FOR-PROFIT INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. FELLOWS SELECTED FOR FOUNDATION FELLOWSHIPS ARE SELECTED THROUGH NATIONWIDE AND INTERNATIONAL COMPETITIONS. THE CLINICAL RESEARCH TRAINING PROGRAM (CRTP) IS OPEN TO ALL THIRD YEAR STUDENTS ENROLLED IN MEDICAL OR DENTAL SCHOOLS. THE WOMEN'S HEALTH FELLOWSHIP PROGRAMS ARE OPEN TO DOCTORAL-LEVEL CANDIDATES WITHIN FIVE YEARS OF RECEIPT OF THE DOCTORAL DEGREE. APPLICATIONS, CONTAINING TRANSCRIPTS AND ESSAYS ON THEIR RESEARCH GOALS ARE SUBMITTED AND REVIEWED BY PANELS OF NIH SCIENTISTS WHO MAKE RECOMMENDATIONS FOR SELECTION. POTENTIAL FELLOWS ARE OFTEN BROUGHT TO THE CAMPUS FOR INTERVIEWS AND FINAL SELECTION. THE FOUNDATION'S FELLOWSHIPS ARE OPEN TO PROFESSIONALS WORKING AT VARIOUS STAGES OF THEIR RESEARCH CAREERS. APPLICANTS TO THE NEUROSCIENCE FELLOWSHIP, FOR EXAMPLE, ARE YOUNG SCIENTISTS WHO WILL BENEFIT FROM EXPERIENCE OF CLINICAL AND BASIC SCIENCE RESEARCH. THE DIRECTOR'S FELLOWSHIP IN COMPLEMENTARY AND ALTERNATIVE MEDICINE RESEARCH SEEKS A MORE EXPERIENCED SCIENTIST WHO IS WELL-POSITIONED TO BECOME A LEADER IN THE FIELD OF COMPLEMENTARY ALTERNATIVE MEDICINE. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Independent Consultant | X | IndependentConsultant |
| Written Employment Contract | X | WrittenEmploymentContract |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | 1 | SeverancePayment |
| Supplemental Nonqual Retire Plan | 0 | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | 0 | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | 0 | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | 0 | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | 0 | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | 0 | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | 0 | AnyNonFixedPayments |
| Initial Contract Exception | 0 | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (11 entries)
| TitleTitle | Base Compensation Filing OrgBaseCompensationFilingOrg | Comp Based On Related OrgsCompBasedOnRelatedOrgs | Bonus Filing OrgBonusFilingOrg | Bonus Related OrgsBonusRelatedOrgs | Other Compensation Filing OrgOtherCompensationFilingOrg | Other Compensation Related OrgsOtherCompensationRelatedOrgs | Deferred Comp Filing OrgDeferredCompFilingOrg | Deferred Comp Related OrgsDeferredCompRelatedOrgs | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs | Total Compensation Filing OrgTotalCompensationFilingOrg | Total Compensation Related OrgsTotalCompensationRelatedOrgs | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg | Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DAVID WHOLLEY | ||||||||||||||
| DIR BIOMARKERS CONSORTIUM | 261607 | 0 | 0 | 0 | 4500 | 0 | 25000 | 0 | 10752 | 0 | 301859 | 0 | 0 | 0 |
| STEPHANIE JAMES | ||||||||||||||
| DIR OF SCIENCE AND GCGH | 269172 | 0 | 0 | 0 | 0 | 0 | 25000 | 0 | 0 | 0 | 294172 | 0 | 0 | 0 |
| ANDREA BARUCHIN | ||||||||||||||
| DIR NIH RELATIONS | 187753 | 0 | 0 | 0 | 200 | 0 | 18795 | 0 | 4956 | 0 | 211704 | 0 | 0 | 0 |
| JULIE TUNE | ||||||||||||||
| CHIEF FINANCIAL OFFICER | 172684 | 0 | 0 | 0 | 500 | 0 | 17318 | 0 | 10752 | 0 | 201254 | 0 | 0 | 0 |
| ANN ASHBY | ||||||||||||||
| DEPUTY EXECUTIVE DIRECTOR | 198038 | 0 | 0 | 0 | 720 | 0 | 19876 | 0 | 10752 | 0 | 229386 | 0 | 0 | 0 |
| JULIA WOLF-RODDA | ||||||||||||||
| DIR PSHIP DEVELOPMENT | 176611 | 0 | 0 | 0 | 0 | 0 | 17661 | 0 | 10752 | 0 | 205024 | 0 | 0 | 0 |
| MICHAEL GOTTLIEB | ||||||||||||||
| ASSOC DIR OF SCIENCE | 220833 | 0 | 0 | 0 | 0 | 0 | 22083 | 0 | 0 | 0 | 242916 | 0 | 0 | 0 |
| JUDITH SIUCIAK | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | 148320 | 0 | 0 | 0 | 900 | 0 | 14922 | 0 | 10752 | 0 | 174894 | 0 | 0 | 0 |
| GAIL LEVINE | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | 135804 | 0 | 0 | 0 | 5000 | 0 | 14080 | 0 | 10752 | 0 | 165636 | 0 | 0 | 0 |
| KAREN TOUNTAS | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | 143830 | 0 | 0 | 0 | 0 | 0 | 14383 | 0 | 10752 | 0 | 168965 | 0 | 0 | 0 |
| SCOTT CAMPBELL | ||||||||||||||
| FORMER EXECUTIVE DIRECTOR AND CEO | 241015 | 0 | 0 | 0 | 0 | 0 | 24101 | 0 | 4956 | 0 | 270072 | 0 | 0 | 0 |
Form990 Schedule J Part III Form990ScheduleJPartIII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Reference | PART I, LINE 4A | ReturnReference |
| Explanation | SCOTT CAMPBELL $155,833 | Explanation |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (13 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| STATEMENT OF ORGANIZATION'S PRIMARY EXEMPT PURPOSE STATEMENT | FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: | THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY THE UNITED STATES CONGRESS TO SUPPORT THE NIH IN ITS MISSION TO IMPROVE HEALTH, BY FORMING AND FACILITATING PUBLIC-PRIVATE PARTNERSHIPS FOR BIOMEDICAL RESEARCH AND TRAINING. THE FOUNDATION BUILDS PARTNERSHIP FOR DISCOVERY AND INNOVATION TO IMPROVE HEALTH. IN 2012, OUR PORTFOLIO OF WORK EMBRACED A BROAD CONSTELLATION OF PARTNERS FROM MANY INSTITUTES AND CENTERS WITHIN THE NIH, FROM THE NONPROFIT SECTOR AS WELL AS THE PRIVATE SECTOR, INCLUDING PHARMACEUTICAL, TECHNOLOGY, RETAIL, AND FOOD AND BEVERAGE INDUSTRIES AND FROM ORGANIZATIONS AS DIVERSE AS THE NATIONAL FOOTBALL LEAGUE AND GOOGLE. |
| PROGRAM ONE: RESEARCH PARTNERSHIPS | FORM 990, PART III, LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS: | IN 2012, FNIH PROGRAMS ENCOMPASSED A BROAD SPECTRUM OF BIOMEDICAL RESEARCH - FROM PRECISE, INNOVATIVE FUNDAMENTAL WORK TO UNDERSTAND DISEASE AND ITS PROGRESSION, TO CLINICAL AND FIELD TRIALS TO EVALUATE POTENTIAL NEW THERAPEUTIC INTERVENTIONS, TO LARGE-SCALE METHODS TO MONITOR THE EFFECTS OF EXISTING MEDICINES. THROUGH FNIH, PRIVATE-SECTOR ORGANIZATIONS WITH AN INTEREST IN A DISEASE OR A NEW TECHNOLOGY CAN TEAM UP WITH THE NIH TO ACCELERATE THE PATHWAY FROM COLLABORATION TO INNOVATION. SPORTS AND HEALTH RESEARCH PROGRAM WITH A $30 MILLION DONATION, THE NATIONAL FOOTBALL LEAGUE BECAME THE FOUNDING PARTNER OF THE FNIH'S NEW SPORTS AND HEALTH RESEARCH PROGRAM. WHILE SPECIFIC INITIATIVES HAVE YET TO BE FINALIZED, POTENTIAL AREAS OF RESEARCH INCLUDE BRAIN INJURY, SUDDEN CARDIAC DEATH, HEAT AND HYDRATION-RELATED ILLNESS, JOINT DISEASE, HEALTH EFFECTS OF PERFORMANCE-ENHANCING SUBSTANCES AND CHRONIC PAIN. TRAUMATIC BRAIN INJURY (TBI) IS AN IMPORTANT AREA OF INTEREST FOR PROFESSIONAL FOOTBALL AND OTHER CONTACT SPORTS, AND RESEARCH TO BETTER UNDERSTAND WAYS TO RECOGNIZE AND PREVENT BRAIN INJURY IS A MAJOR FOCUS OF DISCUSSIONS WITHIN THIS NEW PROGRAM. THE IMPACT OF RESEARCH ON BRAIN INJURY WILL EXTEND FAR BEYOND THE NFL, AS TBI IS THE SIGNATURE WOUND OF SOLDIERS FIGHTING IN IRAQ AND AFGHANISTAN AND EACH YEAR, ACROSS AMERICA, AN ESTIMATED 1.7 MILLION PEOPLE SUFFER A BRAIN INJURY DUE TO TRAUMA. THE SPORTS AND HEALTH RESEARCH PROGRAM AIMS TO ATTRACT FUNDING FROM OTHER DONORS, INCLUDING ADDITIONAL SPORTS ORGANIZATIONS. THE FOUNDING GRANT REPRESENTS THE NFL'S SINGLE LARGEST DONATION TO ANY ORGANIZATION IN THE LEAGUE'S 92 YEARS. BIOMARKERS CONSORTIUM A WIDE-RANGING INITIATIVE TO ADVANCE PERSONALIZED MEDICINE, THE BIOMARKERS CONSORTIUM WORKS TO IDENTIFY MEASURABLE INDICATORS OF BIOLOGICAL AND PATHOLOGICAL PROCESSES TO PREDICT, PREVENT AND TREAT DISEASE. AMONG THE PROJECTS UNDERWAY ARE: I-SPY 2 WOMEN NEWLY DIAGNOSED WITH AGGRESSIVE BREAST CANCER SHOULD HAVE MORE RAPID ACCESS TO PROMISING THERAPIES THANKS TO NEW FOOD AND DRUG ADMINISTRATION (FDA) DRAFT GUIDELINES (OR GUIDANCE) BASED ON THE FNIH I-SPY 2 STUDY. I-SPY 2, A PROJECT OF THE BIOMARKERS CONSORTIUM, IS PIONEERING A NOVEL PROTOCOL TO TEST AND GAIN APPROVAL FOR NEW DRUGS, A PROCESS THAT IS NOTORIOUSLY SLOW AND EXPENSIVE. CURRENTLY, IT CAN TAKE MORE THAN A DECADE TO BRING A NEW CANCER DRUG TO MARKET AT A COST OF MORE THAN $1 BILLION-TIME MANY BREAST CANCER PATIENTS SIMPLY DO NOT HAVE. THE TRIAL'S APPROACH IS GROUNDBREAKING IN TWO WAYS: FIRST, IT IS SCREENING VARIOUS POTENTIAL NEW DRUGS WITHIN THE SAME STUDY; AS THESE CANDIDATE DRUGS ARE MOVED OUT - EITHER FOR NEXT-STAGE TESTING OR BECAUSE THEY FAIL - NEW ONES ARE INTRODUCED. SECOND, INSTEAD OF A ONE-SIZE-FITS-ALL TRIAL, CANDIDATE DRUGS ARE ASSIGNED TO PATIENTS BASED ON THE SPECIFIC CHARACTERISTICS OF THEIR TUMOR. THE DRAFT FDA GUIDANCE ON THE SUBJECT SUGGESTS THAT ONCE THESE NEW DRUGS HAVE SHOWN CLINICAL BENEFIT IN THE I-SPY 2 MODEL, THEY SHOULD BE ELIGIBLE FOR ACCELERATED REGULATORY APPROVAL FOLLOWING A CONFIRMATORY TRIAL. THE I-SPY MODEL CUTS IN HALF THE TIME IT NORMALLY WOULD TAKE TO BRING A DRUG TO MARKET AND CAN DRAMATICALLY LOWER THE COSTS. CONSENSUS DEFINITION OF CLINICALLY IMPORTANT SARCOPENIA THIS BIOMARKERS PROJECT TEAM HAS COMPLETED ITS WORK IN ADVANCING THE FIRST EVIDENCE-BASED DEFINITION OF SARCOPENIA (MUSCLE WEAKNESS), A CONDITION THAT RESULTS IN SERIOUS CONSEQUENCES SUCH AS DISABILITY AND INCREASED MORTALITY. IN THE FIRST PHASE OF THE PROJECT, SIX PRINCIPAL INVESTIGATORS ANALYZED POOLED DATA FROM CLINICAL TRIALS AND LARGE OBSERVATIONAL STUDIES, SUCH AS THE HEALTH ABC AND FRAMINGHAM STUDIES. THEIR FINDINGS, REPORTED AT A FOUR-DAY SARCOPENIA CONSENSUS SUMMIT IN MAY, ARE BEING READIED FOR PUBLICATION. THE NEW DEFINITION WILL ASSIST RESEARCHERS, CLINICIANS AND REGULATORS IN DIAGNOSING SARCOPENIA AND THE CONSENSUS-BUILDING PROCESS WILL SERVE AS A MODEL FOR ARTICULATING OTHER EVIDENCE-BASED DEFINITIONS OF GERIATRIC HEALTH PROBLEMS. ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE 2 NOW IN ITS EIGHTH YEAR, THE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) IS THE LARGEST PUBLIC-PRIVATE BRAIN RESEARCH PARTNERSHIP TO DATE, WITH 28 PRIVATE PARTNERS COORDINATED BY THE FNIH. IT REMAINS THE GOLD STANDARD FOR HOW SUCH PARTNERSHIPS CAN ADVANCE BIOMEDICAL RESEARCH. ADNI DATA, COLLECTED ON THE STUDY'S 1,500 PARTICIPANTS, IS PLACED IN THE SCIENTIFIC PUBLIC DOMAIN TO ENCOURAGE ITS USE BY THE BROADEST RANGE OF INVESTIGATORS POSSIBLE. THE ACCOMPLISHMENTS FROM THIS PROGRAM CONTINUE TO INFORM DEVELOPMENT OF NEW THERAPIES AS WELL AS INFLUENCE ADDITIONAL STUDIES. UNDER THE ORGANIZATION OF THE ALZHEIMER'S ASSOCIATION'S WORLD-WIDE ADNI, SIMILAR WORK IS BEING CARRIED OUT IN ARGENTINA, CHINA, EUROPE, JAPAN, AUSTRALIA, TAIWAN AND SOUTH KOREA. BUILDING ON THE SUCCESS OF THE PROGRAM, ADNI HAS GARNERED ADDITIONAL SUPPORT FROM THE BRIN WOJCICKI FOUNDATION AND THE ALZHEIMER'S ASSOCIATION TO CONDUCT WHOLE GENOME SEQUENCING ON 818 STUDY PARTICIPANTS. THIS EFFORT WILL EXPONENTIALLY INCREASE THE AMOUNT OF GENETIC DATA AVAILABLE TO INVESTIGATORS, LIKELY HIGHLIGHTING A WEALTH OF NEW TARGETS FOR RISK ASSESSMENT, INSIGHTS AND THERAPIES. COMPLEMENTARY TO THE SCOPE OF ADNI, THE PROGRAM'S INVESTIGATORS HAVE RECEIVED SUPPORT FROM THE DEPARTMENT OF DEFENSE TO FOLLOW 300 VIETNAM VETERANS, AGED BETWEEN 60 AND 90 YEARS OLD, TO STUDY WHETHER TRAUMATIC BRAIN INJURY AND/OR POST-TRAUMATIC STRESS DISORDER - BOTH COMMON BATTLEFIELD INJURIES - INCREASE THE RISK OF ALZHEIMER'S DISEASE LATER IN LIFE. SPIROMICS ALTHOUGH IT IS THE THIRD-LEADING CAUSE OF DEATH IN THE UNITED STATES, AFFECTING AS MANY AS 24 MILLION PEOPLE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS STILL POORLY UNDERSTOOD AND TREATMENT OPTIONS ARE LIMITED. SPRIROMICS, OR SUBPOPULATIONS AND INTERMEDIATE OUTCOME MEASURES IN COPD STUDY, IS AN OBSERVATIONAL STUDY WITH TWO MAIN GOALS. THE FIRST IS TO IDENTIFY SUBPOPULATIONS OF COPD PATIENTS THAT SHARE COMMON CHARACTERISTICS. THE SECOND IS TO IDENTIFY BIOMARKERS THAT WILL ENABLE BETTER TRACKING OF THE DISEASE'S PROGRESSION. TOGETHER, THESE EFFORTS SHOULD IMPROVE THE ABILITY OF CLINICAL TRIALS TO DETERMINE WHETHER PARTICULAR THERAPIES ARE WORKING. SIX UNIVERSITY CLINICAL CENTERS ARE WORKING IN PARTNERSHIP WITH THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE TO FOLLOW 3,000 COPD SUFFERERS. OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP AMERICA'S DRUG-APPROVAL PROCESS HAS SET THE GLOBAL STANDARD FOR RIGOROUS SAFETY AND EFFECTIVENESS REVIEW, BUT EVEN WITH CLINICAL TRIALS AND OTHER SAFEGUARDS, IT IS IMPOSSIBLE TO FULLY UNDERSTAND THE IMPACT OF ANY PARTICULAR MEDICAL INTERVENTION UNTIL IT IS WIDELY USED. ONCE DRUGS ARE ON THE MARKET, RESEARCHERS CONTINUE TO STUDY THEM TO IDENTIFY SAFETY ISSUES AND POTENTIAL UNANTICIPATED BENEFITS. IN 2007, RECOGNIZING THAT THE INCREASED USE OF ELECTRONIC HEALTH RECORDS AND AVAILABILITY OF OTHER LARGE SETS OF HEALTH DATA PROVIDED NEW LEARNING OPPORTUNITIES, CONGRESS DIRECTED THE FOOD AND DRUG ADMINISTRATION (FDA) TO CREATE A NEW DRUG SURVEILLANCE PROGRAM TO MORE AGGRESSIVELY IDENTIFY POTENTIAL SAFETY ISSUES. IN RESPONSE, TOGETHER WITH PHRMA AND THE FDA, FNIH LAUNCHED THE OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP (OMOP). THIS INTERDISCIPLINARY, PUBLIC-PRIVATE RESEARCH GROUP IS ENGAGED IN IDENTIFYING THE MOST RELIABLE METHODS FOR ANALYZING HUGE VOLUMES OF DATA DRAWN FROM HETEROGENEOUS SOURCES TO IDENTIFY DRUG SAFETY ISSUES. OVER THE COURSE OF 2011 AND 2012, RESEARCH YIELDED GREATER CONFIDENCE THAT PARTICULAR METHODS USED WITH SPECIFIC TYPES OF DATA CAN RELIABLY IDENTIFY CORRELATIONS BETWEEN INDIVIDUAL MEDICAL INTERVENTIONS AND SPECIFIC HEALTH OUTCOMES. AS EXPERIMENTS CONTINUE TO PROVIDE GREATER UNDERSTANDING OF HOW HEALTH CARE DATA CAN BE ANALYZED EFFECTIVELY, OMOP WILL CONTINUE TO EVALUATE HOW LARGE-SCALE EMPIRICAL EXPERIMENTS CAN BE REFINED FOR MAXIMUM CLINICAL BENEFIT AND IMPROVED DECISION-MAKING. |
| GLOBAL HEALTH COLLABORATING WITH ORGANIZATIONS AROUND THE WORLD, FNIH FURTHERS THE UNDERSTANDING AND CONTROL OF DISEASES THAT SICKEN AND KILL HUNDREDS OF MILLIONS OF PEOPLE EVERY YEAR. WORKING IN THE U.S. AND INTERNATIONALLY, FNIH-FUNDED INVESTIGATORS ARE MAKING STRIDES AGAINST LIFE-THREATENING DISEASES INCLUDING MALARIA, DENGUE, TUBERCULOSIS, ENTERIC INFECTIONS AND MALNUTRITION. GRAND CHALLENGES IN GLOBAL HEALTH THE GRAND CHALLENGES IN GLOBAL HEALTH (GCGH) IS A PARTNERSHIP WITH THE BILL & MELINDA GATES FOUNDATION THAT FOSTERS INNOVATIVE RESEARCH TO ADDRESS SCIENTIFIC OBSTACLES THAT BLOCK PROGRESS AGAINST DISEASES PROMINENT IN DEVELOPING COUNTRIES. FNIH IS INVOLVED WITH SEVERAL GROUNDBREAKING COMPONENTS OF THE PROGRAM. THE VECTOR-BASED CONTROL OF TRANSMISSION: DISCOVERY RESEARCH (VCTR) PROGRAM IS AN EXTENSION OF GCGH FOCUSED ON DEVELOPMENT OF BIOLOGIC, GENETIC OR CHEMICAL STRATEGIES TO CONTROL MOSQUITO-BORNE DISEASES. IN 2012, TESTING OF A PROMISING DENGUE CONTROL TECHNOLOGY THAT ORIGINATED IN AUSTRALIA WAS EXPANDED TO ADDITIONAL FIELD SITES IN BRAZIL AND VIETNAM. RESEARCHERS ARE WORKING TO INHIBIT THE TRANSMISSION OF DENGUE VIRUS THROUGH A BIOCONTROL METHOD - INFECTING THE AEDES MOSQUITOES THAT SPREAD THE DISEASE WITH A BACTERIUM THAT REDUCES VIRAL REPLICATION IN THE MOSQUITO AND, CONSEQUENTLY, THE AMOUNT OF VIRUS PRESENT IN THE INSECTS' SALIVA TO BE PASSED ON WHEN IT BITES. AUSTRALIAN FIELD TRIALS CONTINUE TO COMPARE THE EFFECTS OF DIFFERENT STRAINS OF WOLBACHIA BACTERIA ON VIRAL DEVELOPMENT WITHIN THE MOSQUITOES AS A MARKER TO PREDICT EFFECTS ON DENGUE TRANSMISSION. INVESTIGATORS IN SEVERAL AFRICAN COUNTRIES JOINED A CONSORTIUM WORKING ON A NEW GENETIC METHOD TO DECREASE THE SPREAD OF MALARIA. THE RESEARCHERS ARE DEVELOPING WAYS OF INSERTING AN ENZYME INTO ANOPHELES MOSQUITOES THAT CARRY THE DISEASE. THE ENZYME WILL BE TARGETED TO INACTIVATE A GENE REQUIRED FOR MOSQUITO REPRODUCTION. BY INHIBITING THEIR CAPACITY TO REPRODUCE, THE SCIENTISTS AIM TO REDUCE MOSQUITO NUMBERS BELOW THE LEVEL NECESSARY TO MAINTAIN MALARIA TRANSMISSION. A COMPLETELY DIFFERENT APPROACH TO INTERRUPTING MALARIA TRANSMISSION BRINGS ACADEMIC AND INDUSTRY RESEARCHERS TOGETHER TO SCREEN AND TEST HUNDREDS OF THOUSANDS OF COMPOUNDS FOR THEIR POTENTIAL EFFECTS ON MOSQUITO HOST-SEEKING BEHAVIOR. SEVERAL OF THE MOST EFFECTIVE COMPOUNDS ARE ALREADY BEING PURSUED FOR FURTHER DEVELOPMENT, WITH THE GOAL OF CREATING BETTER REPELLENTS. ETIOLOGY, RISK FACTORS & INTERACTIONS OF ENTERIC INFECTIONS AND MALNUTRITION AND THE CONSEQUENCES FOR CHILD HEALTH & DEVELOPMENT (MAL-ED) THIS PARTNERSHIP WITH THE BILL & MELINDA GATES FOUNDATION AND THE FOGARTY INTERNATIONAL CENTER AT NIH, IS DESIGNED TO INCREASE UNDERSTANDING OF THE COMPLEX INTERACTIONS AMONG ENTERIC INFECTIONS AND MALNUTRITION AND THEIR ASSOCIATION WITH IMPAIRED GROWTH AND COGNITIVE DEVELOPMENT AND POOR VACCINE EFFICACY IN YOUNG CHILDREN. IN FEBRUARY 2012, ENROLLMENT WAS COMPLETED IN A LARGE BIRTH COHORT STUDY. RESEARCHERS ARE MONITORING NEARLY 2,000 CHILDREN - ACROSS EIGHT FIELD SITES IN RURAL AND URBAN SETTINGS ON THREE CONTINENTS - THROUGH THEIR FIRST TWO YEARS OF LIFE. THEY ARE COLLECTING AND TESTING A VARIETY OF BIOSPECIMENS TO IDENTIFY SPECIFIC RISK FACTORS FOR GROWTH AND DEVELOPMENT SHORTFALLS. EARLY DATA SUGGEST INTRIGUING DIFFERENCES AND SIMILARITIES AMONG THE SITES - VALUABLE INSIGHTS THAT WILL INFORM THE DESIGN OF APPROPRIATE INTERVENTIONS. IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS (HIT-TB) THIS PARTNERSHIP WITH THE BILL & MELINDA GATES FOUNDATION AND THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), SCREENS CHEMICAL LIBRARIES TO IDENTIFY MOLECULES THAT COULD LEAD TO BETTER DRUGS AGAINST TUBERCULOSIS. HIV/AIDS VACCINE DEVELOPMENT FNIH SERVES AS THE PRIMARY AWARDEE FOR THREE RESEARCH PROJECTS THAT ARE PART OF THE BILL & MELINDA GATES FOUNDATION'S COLLABORATION FOR AIDS VACCINE DISCOVERY (CAVD). ON EACH PROJECT, THE VACCINE RESEARCH CENTER AT NIAID WORKS IN COLLABORATION WITH OTHER INSTITUTIONS TO DEVELOP NEW VACCINES TO PREVENT HIV/AIDS. IN 2012, PARTNERS AT THE VACCINE RESEARCH CENTER MADE SIGNIFICANT PROGRESS IN CHARACTERIZING T AND B CELL VACCINE RESPONSES. A NEW TECHNOLOGY (FLUIDIGM) ALLOWS RAPID AND ECONOMICAL SCREENING OF HUNDREDS OF SINGLE CELLS FOR MANY DIFFERENT MARKERS, FACILITATING A MORE PRECISE UNDERSTANDING OF AN INDIVIDUAL'S IMMUNE STATUS. THIS ADVANCE HOLDS GREAT PROMISE FOR EXPANDING THE ABILITY TO MONITOR IMMUNE RESPONSES TO VACCINATION OR INFECTION. DISCUSSIONS WITH THE FDA HAVE ADVANCED PLANNING FOR A PROOF-OF-CONCEPT CLINICAL TRIAL WITH THE POTENTIAL TO EXPEDITE REGULATORY REVIEW OF SYNTHETICALLY DESIGNED VACCINE INSERTS. THIS THREE-ARMED TRIAL WILL COMPARE WILD-TYPE HIV ENV VACCINE CONSTRUCTS WITH MOSAIC AND CONSENSUS CONSTRUCTS TO DETERMINE RELATIVE SAFETY AND EFFICACY. THIS APPROACH WILL FACILITATE THE DESIGN OF BROADLY PROTECTIVE HIV VACCINES. | ||
| PROGRAM TWO: FELLOWSHIPS AND TRAINING PROGRAMS | FORM 990, PART III, LINE 4B, OTHER PROGRAM SERVICES: | WHILE TECHNOLOGY PLAYS AN INCREASINGLY VITAL ROLE IN ADVANCING HUMAN HEALTH, PROGRESS IS IMPOSSIBLE WITHOUT A NEW GENERATION OF CAPABLE AND CURIOUS RESEARCHERS. FNIH PROGRAMS IN VARIOUS FORMATS TARGET A WIDE ARRAY OF TOPICS AND EDUCATION LEVELS, MAKING THE WORLD-CLASS METHODS AND RESOURCES OF THE NIH AVAILABLE TO STUDENTS AND RESEARCHERS ALL OVER THE WORLD. MEDICAL RESEARCH SCHOLARS PROGRAM THE INAUGURAL CLASS OF THE MEDICAL RESEARCH SCHOLARS PROGRAM BEGAN TRAINING ON THE NIH CAMPUS LAST FALL. THE PROGRAM WELCOMED 45 OF THE BEST AND BRIGHTEST YOUNG RESEARCHERS FROM 34 MEDICAL, DENTAL AND VETERINARY SCHOOLS ACROSS THE COUNTRY. DURING THE YEAR-LONG PROGRAM, THE STUDENTS CONDUCT BASIC, TRANSLATIONAL OR CLINICAL RESEARCH IN A FIELD OF THEIR CHOICE, GUIDED BY A MENTOR AND A TUTOR. TO FOSTER THE NEXT GENERATION OF MEDICAL RESEARCHERS AND CLINICIAN-SCIENTISTS COMMITTED TO TRANSLATIONAL RESEARCH AND THE PROMISE IT HOLDS FOR THE CONQUEST OF DISEASE, THE PROGRAM IMMERSES STUDENTS IN THE FULL CONTINUUM OF BIOMEDICAL RESEARCH EARLY IN THEIR CAREER TRAINING. IN ADDITION TO THEIR RESEARCH WORK, STUDENTS COMPLETE AN ACADEMIC CURRICULUM AND INTERACT WITH NIH SCIENTIFIC LEADERS - INSTITUTE DIRECTORS, CLINICAL DIRECTORS AND ESTABLISHED INVESTIGATORS. THE PROGRAM MERGES AND BUILDS ON TWO EARLIER, HIGHLY SUCCESSFUL TRAINING PROGRAMS, THE HOWARD HUGHES MEDICAL INSTITUTE-NIH RESEARCH SCHOLARS PROGRAM AND THE CLINICAL RESEARCH TRAINING PROGRAM. THE GOAL IS TO SUPPORT 70 SCHOLARS EACH YEAR. HUMAN GENOME EXHIBITION EMPLOYING THE WORLD-RENOWNED EXPERTISE OF THE SMITHSONIAN INSTITUTION TO INTERPRET COMPLEX CONCEPTS FOR THE GENERAL PUBLIC, A NEW EXHIBITION WILL TELL THE STORY OF THE DISCOVERY OF THE HUMAN GENOME. AN FNIH PARTNERSHIP WITH THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE AND THE NATIONAL MUSEUM OF NATURAL HISTORY, THE INTERACTIVE EXHIBIT WILL OPEN IN JUNE OF 2013 - THE 10TH ANNIVERSARY OF THE MAPPING OF THE HUMAN GENOME AND THE 60TH ANNIVERSARY OF THE DISCOVERY OF THE DOUBLE-HELIX STRUCTURE OF DNA. ONE OF THE GREAT FEATS OF EXPLORATION IN HISTORY, THE HUMAN GENOME PROJECT UNLOCKED A NEW DIMENSION IN SCIENCE AND HEALTHCARE - YET IT REMAINS LARGELY INSCRUTABLE TO THE GENERAL PUBLIC. ACCOMPANIED BY A DYNAMIC EDUCATION AND OUTREACH PROGRAM, THE HANDS-ON EXHIBIT WILL TRACE THE HISTORY OF THE PROJECT AND REVEAL THE ENORMOUS IMPACT GENOMICS HAS HAD ON INDIVIDUALS, HUMANITY AND THE NATURAL WORLD. THEMES WILL INCLUDE HEALTH AND MEDICINE, ETHICS, BIODIVERSITY, ANCESTRY AND WHAT THE FUTURE MAY HOLD. AFTER ITS RUN OF AT LEAST ONE YEAR AT THE NATURAL HISTORY MUSEUM IN WASHINGTON, D.C., THE EXHIBIT WILL TRAVEL NATIONALLY, BRINGING THE WONDERS OF THIS ACHIEVEMENT TO THOUSANDS AROUND THE U.S. |
| PROGRAM THREE: CAPITAL PROJECTS | FORM 990, PART III, LINE 4C, OTHER PROGRAM SERVICES: | THE FOUNDATION'S CAPITAL PROJECTS ENHANCE THE RESEARCH ENVIRONMENT AT NIH, SUPPORTING AND PROMOTING THE IMPORTANT DISCOVERIES THAT RESULT FROM NIH'S LEADING-EDGE WORK. THE EDMOND J. SAFRA FAMILY LODGE, FOR EXAMPLE, OPENED IN 2005 TO SERVE AS A COMFORTABLE HOME-AWAY-FROM-HOME FOR FAMILIES THAT COME TO NIH'S CAMPUS IN BETHESDA, MARYLAND TO ACCOMPANY PATIENTS WHO ARE PARTICIPATING IN CLINICAL TRIALS OR RECEIVING TREATMENT AT NIH'S CLINICAL CENTER. SO FAR, THE LODGE HAS HOSTED MORE THAN 40,000 FAMILY MEMBERS AND CAREGIVERS OF ADULT PATIENTS FROM ALL OVER THE WORLD. |
| MEMORIALS, AWARDS AND EVENTS | FORM 990, PART III, LINE 4C, OTHER PROGRAM SERVICES: | COLLABORATION HAPPENS WHEN PEOPLE CONNECT. THAT IS WHY MANAGING AND ORGANIZING MEETINGS AND EVENTS IS FUNDAMENTAL TO THE WORK OF THE FNIH. FROM LECTURES AND WORKSHOPS TO COLLABORATIVE SUMMITS, TELECONFERENCES AND MEDIA OPPORTUNITIES, THE FNIH FACILITATED MORE THAN 60 EVENTS IN 2012 - SPANNING THE GLOBE AND DOZENS OF FIELDS OF RESEARCH. |
| FORM 990, PART VI, SECTION B, LINE 11 | PRIOR TO THE SUBMISSION OF THE FOUNDATION FOR NIH'S FORM 990 TO THE INTERNAL REVENUE SERVICE, EACH VOTING MEMBER OF THE BOARD OF DIRECTORS SHALL BE PROVIDED WITH A COPY OF THE FINAL FORM 990 AS COMPLETED BY THE CHIEF FINANCIAL OFFICER. BOARD DIRECTORS SHALL BE PROVIDED WITH AT LEAST TEN BUSINESS DAYS TO REVIEW THE FORM AND RAISE QUESTIONS, MAKE SUGGESTIONS, AND ADDRESS ANY POTENTIAL PROBLEMS OR CONCERNS WITH THE CHIEF FINANCIAL OFFICER. A SPECIAL MEETING OF THE GOVERNANCE COMMITTEE WILL BE CALLED TO REVIEW THE SUGGESTED CHANGES FROM THE BOARD DIRECTORS AND TO APPROVE THE FINAL VERSION OF THE FORM 990 FOR SUBMISSION. | |
| FORM 990, PART VI, SECTION B, LINE 12C | THE FOUNDATION REQUIRES DIRECTORS, OFFICERS, VOLUNTEER COMMITTEE MEMBERS, AND STAFF MEMBERS TO DISCLOSE REAL AND APPARENT CONFLICTS OF INTEREST FOR THEMSELVES AND THEIR FAMILY MEMBERS AND TO ANNUALLY SIGN A STATEMENT OF COMPLIANCE. AFTER A CONFLICT OR AN APPARENT CONFLICT OF INTEREST HAS BEEN DISCLOSED, THE BOARD OF DIRECTORS OR THE BOARD COMMITTEE, OR THEIR DESIGNEE, IN THE ABSENCE OF THE INTERESTED PERSON, SHALL DETERMINE IF THE CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST EXISTS AND IS MATERIAL AND WILL DECIDE HOW IT IS TO BE MANAGED OR ELIMINATED. | |
| FORM 990, PART VI, SECTION B, LINE 15 | IN 2008, A CONSULTANT WAS HIRED TO REVIEW, ANALYZE AND DEVELOP A PROCESS OF DETERMINING SALARIES FOR ALL EMPLOYEES OF THE ORGANIZATION. ALL EMPLOYEES WERE INTERVIEWED AND POSITION DESCRIPTIONS DEVELOPED OR AMENDED AS NEEDED. USING MARKET DATA, THE CONSULTANT DEVELOPED PAY BANDS FOR ALL POSITIONS. FINAL RECOMMENDATIONS WERE REVIEWED BY THE EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR'S COMPENSATION IS REVIEWED AND DETERMINED BY THE EXECUTIVE COMMITTEE OF THE BOARD USING LOCAL MARKET DATA. | |
| FORM 990, PART VI, SECTION C, LINE 19 | ALL DOCUMENTS ARE AVAILABLE UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS ARE POSTED TO THE ORGANIZATION'S WEBSITE. | |
| CHANGES IN NET ASSETS OR FUND BALANCES: | FORM 990, PART XI, LINE 9: | REDUCTION IN FUTURE PLEDGES -1,275,000. |
| FORM 990, PART XII, LINE 2C: | PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. | |
| FORM 990, PART XI, LINE 9, OTHER CHANGES IN NET ASSETS OR FUND BALANCES: | DURING 2012, FNIH WAS NOTIFIED BY TWO DONORS THAT THEY COULD NO LONGER SUPPORT THE PROJECT WHICH THEY ORIGINALLY PROMISED TO SUPPORT OVER MULTIPLE YEARS. FNIH RECORDED $1,275,000 AS A REDUCTION IN FUTURE PLEDGES AS OF 12/31/2012. |
Comments